Insider Trading activities of Warner Chilcott Ltd insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Warner Chilcott Ltd since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Warner Chilcott Ltd since year 2005. Table 2 shows the detailed insider transactions of Warner Chilcott Ltd since 2005. The reporting company's ticker symbol is WCRX. The reporting company's CIK number is 1323854.
The total value of stock buying since 2005 is $389,136.
The total value of stock sales since 2005 is $5,014,006,576.
The total value of stock option exercises since 2005 is $320,756.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Warner Chilcott Ltd (WCRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-07 0 $0 535 $10,635 0 $0
2013-04 0 $0 703 $9,427 0 $0
2013-03 0 $0 10,592,274 $142,677,781 0 $0
2013-02 0 $0 95,762 $1,331,065 31,737 $0
2013-01 0 $0 39,979 $539,002 0 $0
2012-11 0 $0 11,491,618 $132,369,361 0 $0
2012-10 0 $0 341 $4,620 0 $0
2012-09 0 $0 125,913,120 $1,649,461,868 0 $0
2012-07 0 $0 355 $6,375 0 $0
2012-04 0 $0 703 $11,915 0 $0
2012-03 0 $0 14,404 $244,850 0 $0
2012-02 0 $0 15,493 $260,631 4,970 $0
2012-01 0 $0 47,712 $807,823 0 $0
2011-10 0 $0 2,766 $45,504 0 $0
2011-06 0 $0 179,563 $4,014,777 0 $0
2011-04 0 $0 703 $16,379 0 $0
2011-03 0 $0 66,106,023 $1,490,703,291 0 $0
2011-01 0 $0 131,577 $3,082,571 0 $0
2010-10 0 $0 2,467 $59,701 0 $0
2010-09 0 $0 19,350,896 $420,905,263 0 $0
2010-08 0 $0 0 $0 19,176 $320,756
2010-03 0 $0 8,855,906 $223,434,305 0 $0
2010-01 0 $0 32,670 $920,850 0 $0
2009-11 0 $0 42,850,328 $942,845,976 0 $0
2009-09 0 $0 3,880 $77,125 0 $0
2009-01 0 $0 3,156 $44,184 0 $0
2008-09 0 $0 3,675 $56,230 0 $0
2008-03 12,500 $197,487 0 $0 0 $0
2007-09 0 $0 3,728 $65,067 0 $0
2007-03 10,000 $147,700 0 $0 0 $0
2006-08 2,500 $43,949 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Warner Chilcott Ltd insiders (WCRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-07-01 Sullivan Ryan T (VP, General Counsel & Secr.) Sale 169 19.88 3,359
2013-07-01 Halstead Michael (Senior V.P., Corp. Development) Sale 366 19.88 7,276
2013-04-01 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 703 13.41 9,427
2013-03-04 Connaughton John (Director) Sale 10,590,608 13.47 142,655,489
2013-03-01 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,666 13.38 22,292
2013-02-28 Rodriguez Rama Francisco (Senior V.P., Tech. Operations) Sale 820 13.46 11,040
2013-02-28 Fenton Andrew (Senior V.P., CIO) Sale 1,390 13.46 18,714
2013-02-28 Halstead Michael (Senior V.P., Corp. Development) Sale 1,747 13.46 23,521
2013-02-28 Fuhrmann Rochelle (Senior V.P., Finance) Sale 1,728 13.46 23,265
2013-02-28 Gilligan Claire A (Senior V.P., Quality) Sale 2,354 13.46 31,694
2013-02-28 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 15,869 13.46 213,660
2013-02-28 Boissonneault Roger M (CEO & President) Sale 18,730 13.46 252,180
2013-02-28 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,324 13.46 17,826
2013-02-28 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,728 13.46 23,265
2013-02-27 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Option Ex 31,737 .00 0
2013-02-19 Fenton Andrew (Senior V.P., CIO) Sale 419 14.53 6,087
2013-02-19 Halstead Michael (Senior V.P., Corp. Development) Sale 419 14.53 6,087
2013-02-19 Fuhrmann Rochelle (Senior V.P., Finance) Sale 767 14.53 11,142
2013-02-19 Gilligan Claire A (Senior V.P., Quality) Sale 1,045 14.53 15,181
2013-02-19 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 2,562 14.53 37,220
2013-02-19 Boissonneault Roger M (CEO & President) Sale 7,928 14.53 115,177
2013-02-19 Cross Leland H (Senior V.P., Tech. Operations) Sale 553 14.53 8,033
2013-02-19 Ellman Herman (Senior V.P., Clinical Devel.) Sale 691 14.53 10,038
2013-02-19 Herendeen Paul (Exec. V.P. and CFO) Sale 1,969 14.53 28,605
2013-02-19 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 767 14.53 11,142
2013-02-01 Fenton Andrew (Senior V.P., CIO) Sale 996 14.18 14,121
2013-02-01 Halstead Michael (Senior V.P., Corp. Development) Sale 998 14.18 14,149
2013-02-01 Fuhrmann Rochelle (Senior V.P., Finance) Sale 998 14.18 14,149
2013-02-01 Gilligan Claire A (Senior V.P., Quality) Sale 1,377 14.18 19,523
2013-02-01 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 13,790 14.18 195,514
2013-02-01 Boissonneault Roger M (CEO & President) Sale 9,125 14.18 129,374
2013-02-01 Cross Leland H (Senior V.P., Tech. Operations) Sale 808 14.18 11,455
2013-02-01 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,010 14.18 14,319
2013-02-01 Herendeen Paul (Exec. V.P. and CFO) Sale 2,840 14.18 40,265
2013-02-01 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,010 14.18 14,319
2013-01-30 Fenton Andrew (Senior V.P., CIO) Sale 351 13.38 4,697
2013-01-30 Halstead Michael (Senior V.P., Corp. Development) Sale 320 13.38 4,282
2013-01-30 Fuhrmann Rochelle (Senior V.P., Finance) Sale 282 13.38 3,774
2013-01-30 Gilligan Claire A (Senior V.P., Quality) Sale 489 13.38 6,544
2013-01-30 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 2,215 13.90 30,792
2013-01-30 Boissonneault Roger M (CEO & President) Sale 8,470 13.38 113,362
2013-01-30 Cross Leland H (Senior V.P., Tech. Operations) Sale 465 13.38 6,223
2013-01-30 Ellman Herman (Senior V.P., Clinical Devel.) Sale 586 13.38 7,843
2013-01-30 Herendeen Paul (Exec. V.P. and CFO) Sale 2,208 13.38 29,551
2013-01-30 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 591 13.38 7,909
2013-01-22 Fenton Andrew (Senior V.P., CIO) Sale 621 13.50 8,383
2013-01-22 Halstead Michael (Senior V.P., Corp. Development) Sale 488 13.50 6,588
2013-01-22 Fuhrmann Rochelle (Senior V.P., Finance) Sale 488 13.50 6,588
2013-01-22 Gilligan Claire A (Senior V.P., Quality) Sale 949 13.50 12,811
2013-01-22 Boissonneault Roger M (CEO & President) Sale 13,924 13.50 187,974
2013-01-22 Cross Leland H (Senior V.P., Tech. Operations) Sale 839 13.50 11,326
2013-01-22 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,166 13.50 15,741
2013-01-22 Herendeen Paul (Exec. V.P. and CFO) Sale 4,305 13.50 58,117
2013-01-22 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,222 13.50 16,497
2012-11-28 Murray Stephen P Sale 6,491,618 11.41 74,069,361
2012-11-20 Murray Stephen P Sale 5,000,000 11.66 58,300,000
2012-10-01 Halstead Michael (Senior V.P., Corp. Development) Sale 77 13.55 1,043
2012-10-01 Gilligan Claire A (Senior V.P., Quality) Sale 264 13.55 3,577
2012-09-11 Bain Capital (wc) Netherlands B.v (10% Owner) Sale 12,890,449 13.10 168,864,881
2012-09-11 J.p. Morgan Partners Global Investors (cayman/selldown) Iii, L.p. Sale 28,762,425 13.10 376,787,767
2012-09-11 Ellman Herman (Senior V.P., Clinical Devel.) Sale 23,500 13.10 307,850
2012-09-11 Hara Izumi (Senior V.P.) Sale 126,993 13.10 1,663,608
2012-09-11 Herendeen Paul (Exec. V.P. and CFO) Sale 309,240 13.10 4,051,044
2012-09-11 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 147,639 13.10 1,934,070
2012-09-11 Murray Stephen P Sale 14,000,000 13.10 183,400,000
2012-09-11 Jpmp Capital Corp Sale 28,762,425 13.10 376,787,767
2012-09-11 Abbrecht Todd M Sale 14,000,000 13.10 183,400,000
2012-09-11 Thomas H Lee Advisors Alternative V Ltd Ldc Sale 14,000,000 13.10 183,400,000
2012-09-11 Connaughton John (Director) Sale 12,890,449 13.10 168,864,881
2012-07-02 Halstead Michael (Senior V.P., Corp. Development) Sale 355 17.96 6,375
2012-04-02 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 703 16.95 11,915
2012-03-01 Fenton Andrew (Senior V.P., CIO) Sale 386 17.00 6,561
2012-03-01 Halstead Michael (Senior V.P., Corp. Development) Sale 725 17.00 12,324
2012-03-01 Fuhrmann Rochelle (Senior V.P., Finance) Sale 710 17.00 12,069
2012-03-01 Gilligan Claire A (Senior V.P., Quality) Sale 973 17.00 16,540
2012-03-01 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 2,485 17.00 42,242
2012-03-01 Boissonneault Roger M (CEO & President) Sale 5,320 17.00 90,434
2012-03-01 Cross Leland H (Senior V.P., Tech. Operations) Sale 558 17.00 9,485
2012-03-01 Hara Izumi (Sr. VP, Gen. Counsel & Sec.) Sale 710 17.00 12,069
2012-03-01 Herendeen Paul (Exec. V.P. and CFO) Sale 1,827 17.00 31,057
2012-03-01 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 710 17.00 12,069
2012-02-29 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Option Ex 4,970 .00 0
2012-02-21 Fenton Andrew (Senior V.P., CIO) Sale 409 16.82 6,880
2012-02-21 Halstead Michael (Senior V.P., Corp. Development) Sale 409 16.82 6,880
2012-02-21 Fuhrmann Rochelle (Senior V.P., Finance) Sale 752 16.82 12,650
2012-02-21 Gilligan Claire A (Senior V.P., Quality) Sale 1,030 16.82 17,327
2012-02-21 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 2,561 16.82 43,083
2012-02-21 Boissonneault Roger M (CEO & President) Sale 5,628 16.82 94,679
2012-02-21 Cross Leland H (Senior V.P., Tech. Operations) Sale 590 16.82 9,925
2012-02-21 Ellman Herman (Senior V.P., Clinical Devel.) Sale 677 16.82 11,389
2012-02-21 Hara Izumi (Sr. VP, Gen. Counsel & Sec.) Sale 752 16.82 12,650
2012-02-21 Herendeen Paul (Exec. V.P. and CFO) Sale 1,933 16.82 32,518
2012-02-21 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 752 16.82 12,650
2012-01-30 Fenton Andrew (Senior V.P., CIO) Sale 351 16.45 5,774
2012-01-30 Halstead Michael (Senior V.P., Corp. Development) Sale 320 16.45 5,264
2012-01-30 Fuhrmann Rochelle (Senior V.P., Finance) Sale 281 16.45 4,623
2012-01-30 Gilligan Claire A (Senior V.P., Quality) Sale 480 16.45 7,896
2012-01-30 Van Zoonen Marinus Johannes (President, Europe/Int'l & Mkt.) Sale 2,215 16.45 36,441
2012-01-30 Boissonneault Roger M (CEO & President) Sale 8,317 16.45 136,831
2012-01-30 Cross Leland H (Senior V.P., Tech. Operations) Sale 504 16.45 8,291
2012-01-30 Ellman Herman (Senior V.P., Clinical Devel.) Sale 579 16.45 9,525
2012-01-30 Hara Izumi (Sr. VP, Gen. Counsel & Sec.) Sale 635 16.45 10,447
2012-01-30 Herendeen Paul (Exec. V.P. and CFO) Sale 2,187 16.45 35,980
2012-01-30 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 579 16.45 9,525
2012-01-23 Fenton Andrew (Senior V.P., CIO) Sale 621 17.32 10,755
2012-01-23 Halstead Michael (Senior V.P., Corp. Development) Sale 487 17.32 8,434
2012-01-23 Fuhrmann Rochelle (Senior V.P., Finance) Sale 487 17.32 8,434
2012-01-23 Gilligan Claire A (Senior V.P., Quality) Sale 933 17.32 16,159
2012-01-23 Boissonneault Roger M (CEO & President) Sale 13,652 17.32 236,452
2012-01-23 Cross Leland H (Senior V.P., Tech. Operations) Sale 921 17.32 15,951
2012-01-23 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,169 17.32 20,247
2012-01-23 Hara Izumi (Sr. VP, Gen. Counsel & Sec.) Sale 1,169 17.32 20,247
2012-01-23 Herendeen Paul (Exec. V.P. and CFO) Sale 4,149 17.32 71,860
2012-01-23 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,225 17.32 21,217
2012-01-11 Fenton Andrew (Senior V.P., CIO) Sale 558 16.66 9,296
2012-01-11 Halstead Michael (Senior V.P., Corp. Development) Sale 452 16.66 7,530
2012-01-11 Fuhrmann Rochelle (Senior V.P., Finance) Sale 411 16.66 6,847
2012-01-11 Gilligan Claire A (Senior V.P., Quality) Sale 839 16.66 13,977
2012-01-11 Cross Leland H (Senior V.P., Tech. Operations) Sale 908 16.66 15,127
2012-01-11 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,042 16.66 17,359
2012-01-11 Hara Izumi (Sr. VP, Gen. Counsel & Sec.) Sale 1,095 16.66 18,242
2012-01-11 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,146 16.66 19,092
2011-10-21 Fawzi Mahdi B (President, Research & Develop.) Sale 2,418 16.80 40,622
2011-10-03 Halstead Michael (Senior V.P., Corp. Development) Sale 78 14.03 1,094
2011-10-03 Gilligan Claire A (Senior V.P., Quality) Sale 270 14.03 3,788
2011-06-10 Cross Leland H (Senior V.P., Tech. Operations) Sale 79,563 22.29 1,773,777
2011-06-09 Cross Leland H (Senior V.P., Tech. Operations) Sale 100,000 22.41 2,241,000
2011-04-01 Van Zoonen Marinus Johannes (Pres., Europe/Int'l&Glob. Mkt.) Sale 703 23.30 16,379
2011-03-30 Bain Capital (wc) Netherlands B.v (10% Owner) Sale 446,196 22.44 10,010,853
2011-03-30 Gilligan Claire A (Senior V.P. Global Quality) Sale 1,543 23.25 35,874
2011-03-30 J.p. Morgan Partners Global Investors (cayman/selldown) Iii, L.p. (10% Owner) Sale 932,389 22.44 20,919,079
2011-03-30 Bruno Anthony D (Exec. V.P., Corp. Development) Sale 16,848 23.25 391,716
2011-03-30 Ellman Herman (Senior V.P., Clinical Devel.) Sale 3,546 23.25 82,444
2011-03-30 Hara Izumi (Sr. VP, Gen. Counsel & Sec.) Sale 3,713 23.25 86,327
2011-03-30 Herendeen Paul (Exec. V.P. and CFO) Sale 15,406 23.25 358,189
2011-03-30 Reichel Carl W (President, Pharmaceuticals) Sale 18,020 23.25 418,965
2011-03-30 Murray Stephen P (Director) Sale 466,194 22.44 10,459,528
2011-03-30 Jpmp Capital Corp (10% Owner) Sale 932,389 22.44 20,919,079
2011-03-30 Abbrecht Todd M Sale 466,194 22.44 10,461,393
2011-03-30 Connaughton John (Director) Sale 446,196 22.44 10,010,853
2011-03-16 Bain Capital (wc) Netherlands B.v (10% Owner) Sale 6,919,748 22.44 155,251,466
2011-03-16 Gilligan Claire A (Senior V.P. Global Quality) Sale 26,411 23.25 614,055
2011-03-16 J.p. Morgan Partners Global Investors (cayman/selldown) Iii, L.p. (10% Owner) Sale 15,722,194 22.44 352,743,144
2011-03-16 Bruno Anthony D (Exec. V.P., Corp. Development) Sale 400,000 23.25 9,300,000
2011-03-16 Ellman Herman (Senior V.P., Clinical Devel.) Sale 60,668 23.25 1,410,531
2011-03-16 Hara Izumi (Sr. VP, Gen. Counsel & Sec.) Sale 63,531 23.25 1,477,095
2011-03-16 Herendeen Paul (Exec. V.P. and CFO) Sale 400,000 23.25 9,300,000
2011-03-16 Reichel Carl W (President, Pharmaceuticals) Sale 400,000 23.25 9,300,000
2011-03-16 Jpmp Capital Corp (10% Owner) Sale 15,722,194 22.44 352,743,144
2011-03-16 Abbrecht Todd M Sale 7,861,448 23.25 182,778,666
2011-03-16 Connaughton John (Director) Sale 6,919,748 22.44 155,251,466
2011-03-16 Murray Stephen (Director) Sale 7,861,447 22.44 176,379,424
2011-01-31 Fuhrmann Rochelle (Senior V.P., Global Finance) Sale 834 23.35 19,473
2011-01-31 Gilligan Claire A (Senior V.P. Global Quality) Sale 1,422 23.35 33,201
2011-01-31 Van Zoonen Marinus Johannes (Pres., Europe/Int'l&Glob. Mkt.) Sale 6,645 23.35 155,154
2011-01-31 Boissonneault Roger M (CEO & President) Sale 24,684 23.35 576,345
2011-01-31 Bruno Anthony D (Exec. V.P., Corp. Development) Sale 6,456 23.35 150,741
2011-01-31 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,716 23.35 40,065
2011-01-31 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,716 23.35 40,065
2011-01-31 Herendeen Paul (Exec. V.P. and CFO) Sale 6,456 23.35 150,741
2011-01-31 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,716 23.35 40,065
2011-01-31 Reichel Carl W (President, Pharmaceuticals) Sale 6,456 23.35 150,741
2011-01-21 Fuhrmann Rochelle (Senior V.P., Global Finance) Sale 485 23.62 11,456
2011-01-21 Gilligan Claire A (Senior V.P. Global Quality) Sale 929 23.62 21,944
2011-01-21 Boissonneault Roger M (CEO & President) Sale 13,580 23.62 320,786
2011-01-21 Bruno Anthony D (Exec. V.P., Corp. Development) Sale 4,097 23.62 96,779
2011-01-21 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,054 23.62 24,897
2011-01-21 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,164 23.62 27,496
2011-01-21 Herendeen Paul (Exec. V.P. and CFO) Sale 4,096 23.62 96,755
2011-01-21 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,219 23.62 28,795
2011-01-21 Reichel Carl W (President, Pharmaceuticals) Sale 4,096 23.62 96,755
2011-01-11 Gilligan Claire A (Senior V.P. Global Quality) Sale 829 23.85 19,771
2011-01-11 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,030 23.85 24,565
2011-01-11 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,030 23.85 24,565
2011-01-11 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,133 23.85 27,022
2010-10-21 Fawzi Mahdi B (President, Research & Develop.) Sale 2,467 24.20 59,701
2010-09-30 Credit Suisse Ag/ Sale 15,000,000 21.48 322,200,000
2010-09-29 Credit Suisse Ag/ Sale 322,797 22.50 7,263,255
2010-09-28 Credit Suisse Ag/ Sale 575,000 22.53 12,955,325
2010-09-27 Alpinvest Partners Later Stage Co-investments Custodian Ii B.v. (Other) Sale 651,028 22.68 14,765,315
2010-09-24 Alpinvest Partners Later Stage Co-investments Custodian Ii B.v. (Other) Sale 1,649,645 22.78 37,578,913
2010-09-23 Alpinvest Partners Later Stage Co-investments Custodian Ii B.v. (Other) Sale 393,237 22.85 8,985,465
2010-09-22 Gilligan Claire A (Senior V.P. Global Quality) Sale 956 23.05 22,033
2010-09-22 Alpinvest Partners Later Stage Co-investments Custodian Ii B.v. (Other) Sale 481,240 22.92 11,030,020
2010-09-22 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,171 23.05 26,989
2010-09-22 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,171 23.05 26,989
2010-09-22 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,422 23.05 32,774
2010-09-14 Credit Suisse Ag/ Sale 124,717 22.01 2,745,395
2010-09-13 Credit Suisse Ag/ Sale 38,712 22.05 853,677
2010-09-10 Credit Suisse Ag/ Sale 109,800 22.03 2,419,113
2010-08-13 Bloem James H (Director) Option Ex 19,176 16.73 320,756
2010-03-25 Alpinvest Partners Later Stage Co-investments Custodian Ii B.v. (Other) Sale 229,892 26.73 6,145,013
2010-03-25 Credit Suisse Ag/ Sale 8,626,014 25.19 217,289,292
2010-01-21 Boissonneault Roger M (CEO & President) Sale 13,658 28.17 384,773
2010-01-21 Bruno Anthony D (Exec. V.P., Corp. Development) Sale 4,120 28.17 116,068
2010-01-21 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,052 28.17 29,636
2010-01-21 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,162 28.17 32,735
2010-01-21 Herendeen Paul (Exec. V.P. and CFO) Sale 4,120 28.17 116,068
2010-01-21 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,217 28.17 34,285
2010-01-21 Reichel Carl W (President, Pharmaceuticals) Sale 4,120 28.17 116,068
2010-01-11 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,039 28.32 29,424
2010-01-11 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,039 28.32 29,424
2010-01-11 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,143 28.32 32,369
2009-11-25 Alpinvest Partners Later Stage Co-investments Custodian Ii B.v. (Other) Sale 1,334,122 22.25 29,684,214
2009-11-25 Bcip Trust Associates Iii-b (10% Owner) Sale 3,946,020 22.25 87,798,945
2009-11-25 Boissonneault Roger M (CEO & President) Sale 322,736 22.25 7,180,876
2009-11-25 Bruno Anthony D (Exec. V.P., Corp. Development) Sale 156,375 22.25 3,479,343
2009-11-25 Ellman Herman (Senior V.P., Clinical Devel) Sale 27,127 22.25 603,575
2009-11-25 Hara Izumi (Sr. VP, Gen. Counsel & Sec.) Sale 27,559 22.25 613,187
2009-11-25 Herendeen Paul (Exec. V.P. and CFO) Sale 147,846 22.25 3,289,573
2009-11-25 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 24,510 22.25 545,347
2009-11-25 Reichel Carl W (President, Pharmaceuticals) Sale 164,528 22.25 3,660,748
2009-11-25 Jpmp Capital Corp (10% Owner) Sale 8,452,290 21.42 181,014,242
2009-11-25 Abbrecht Todd M Sale 4,159,304 22.25 92,544,514
2009-11-25 Thomas H Lee Alternative Fund V Lp Sale 3,253,707 22.25 72,394,980
2009-11-25 Thomas H Lee Advisors Alternative V Ltd Ldc Sale 4,142,743 22.25 92,176,031
2009-11-25 Thl Advisors Alternative V Lp Sale 4,142,743 22.25 92,176,031
2009-11-25 Connaughton John (Director) Sale 3,946,020 22.25 87,798,945
2009-11-25 Murray Stephen (Director) Sale 4,226,145 21.42 90,507,121
2009-11-25 Credit Suisse Ag/ (10% Owner) Sale 4,376,553 22.25 97,378,304
2009-09-22 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,207 19.88 23,992
2009-09-22 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,207 19.88 23,992
2009-09-22 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,466 19.88 29,141
2009-01-12 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,018 14.00 14,252
2009-01-12 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,018 14.00 14,252
2009-01-12 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,120 14.00 15,680
2008-09-22 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,150 15.30 17,596
2008-09-22 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,129 15.30 17,274
2008-09-22 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,396 15.30 21,360
2008-03-13 Bloem James H (Director) Buy 2,500 16.40 40,987
2008-03-07 Burgstahler David F (Director) Buy 10,000 15.65 156,500
2007-09-24 Cross Leland H (Senior V.P., Tech. Operations) Sale 1,160 17.45 20,246
2007-09-24 Ellman Herman (Senior V.P., Clinical Devel.) Sale 1,160 17.45 20,246
2007-09-24 Howard Alvin D (Sr. V.P., Regulatory Affairs) Sale 1,408 17.45 24,575
2007-03-12 Burgstahler David F (Director) Buy 10,000 14.77 147,700
2006-08-20 Bloem James H (Director) Buy 2,500 17.58 43,949

Insider trading activities including stock purchases, stock sales, and option exercises of WCRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Warner Chilcott Ltd (symbol WCRX, CIK number 1323854) see the Securities and Exchange Commission (SEC) website.